Astragalin is an orally bioavailable flavonoid that has been isolated from the leaves of D. kaki and R. agrestis and has anti-inflammatory activity.

Market Analysis and Insights: Global and China Astragalin Market
This report focuses on global and China Astragalin market.
In 2020, the global Astragalin market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Astragalin market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Astragalin Scope and Market Size
Astragalin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Astragalin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Astragalin market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%

Segment by Application
Research
Medical

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Merck
Biorbyt
Biosynth Carbosynth
Cayman Chemical
BioVision
Santa Cruz Biotechnology
Adooq Bioscience
AA Blocks
AbMole
Carl Roth
Selleck Chemicals
Aladdin